Home/ Supplements/ Omega 3/ Omega 3-6-9 3600 mg

Omega 3-6-9 3600 mg

product on market Softgel Capsule Safrel Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product combines fish, flaxseed, and borage oils to provide a blend of omega-3, 6, and 9 fatty acids. Strong evidence supports the role of these essential fats in maintaining cardiovascular health and managing systemic inflammation. However, overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Omega 3-6-9 3600 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Softgel(s)
Serving Size
60
Servings
Fat/Fatty Acid
Product Type
40%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
30 Calorie(s)
Total Fat
3.5 Gram(s) (4% DV)
1200 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
1200 mg
Market median: 1000.0mg (212 products) 12 studies (A:0, B:3)
Borage Oil
1200 mg

Other Ingredients

Gelatin Glycerin
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: Take three (3) softgels daily, preferable with food.

Warnings & Precautions

Warning: Consult your doctor if you are pregnant, nursing, taking any medications or have a medical condition.

Keep out of reach of children.

Do not use if seal under cap is broken or missing.

Formulation Notes

No: milk, egg, tree nuts, peanuts, yeast.

Omega 3-6-9 3,600 mg Fish Oil Fish, Flax, Borage Oils

Made in U.S.A. Healthy heart support Brain, eyes & joints

Additional Information

Store at room temperature.

Metadata

Product Details

UPC / SKU3 71309 00005 4
DSLD Entry Date2025-05-21
Product TypeFat/Fatty Acid
FormSoftgel Capsule
BrandSafrel
DSLD ID328949
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.